Medicare Enrolled
Dr. Timothy Miller, MD
Gastroenterology · Temple, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Miller from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Miller?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Miller
Dr. Timothy Miller is a gastroenterology specialist in Temple, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Miller performed 1,422 Medicare services across 1,247 unique beneficiaries.
Between the years covered by Open Payments, Dr. Miller received a total of $101,946 from 62 pharmaceutical and/or device companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Miller is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 13% volume in TX
$101,946 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,422
Medicare services
Top 13% in TX for gastroenterology
1,247
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~79 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
269 | $84 | $217 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
197 | $59 | $146 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
110 | $60 | $148 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
102 | $124 | $847 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
94 | $78 | $680 |
| Dilation of esophagus | 81 | $30 | $334 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
77 | $78 | $518 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
73 | $105 | $333 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
72 | $193 | $1,067 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
69 | $133 | $411 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
45 | $174 | $778 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
37 | $100 | $278 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
32 | $64 | $219 |
| Endoscopic ultrasound-guided needle biopsy A procedure using an ultrasound-equipped endoscope to guide a needle for tissue sampling of the esophagus, stomach, or upper small bowel. |
24 | $182 | $1,110 |
| Radiologist review of bile duct tube placement imaging A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope. |
22 | $18 | $146 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
22 | $40 | $151 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
19 | $174 | $781 |
| Endoscopic ultrasound of esophagus, stomach, or upper small bowel An ultrasound exam of the esophagus, stomach, and/or upper small bowel performed using a flexible endoscope. |
16 | $142 | $955 |
| Endoscopic removal of bile or pancreatic duct stone A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts. |
16 | $168 | $1,537 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $28 | $100 |
| Endoscopic ligation of esophageal or gastric varices A procedure using a flexible endoscope to tie off dilated veins in the stomach or esophagus. |
11 | $186 | $1,036 |
| Endoscopic incision of pancreatic outlet A procedure where a flexible endoscope is used to make an incision in the pancreatic outlet. |
11 | $26 | $1,509 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
11 | $133 | $781 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$101,946
Total received (2018-2024)
Avg $14,564/year across 7 years
Top 3% in TX for gastroenterology
62
Companies
727
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$89,498 (87.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,448 (12.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$20,083
2023
$69,017
2022
$6,841
2021
$2,353
2020
$897
2019
$1,259
2018
$1,495
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Ferring Pharmaceuticals Inc.
$77,431
Phathom Pharmaceuticals, Inc.
$7,729
AIMMUNE THERAPEUTICS, INC.
$4,339
ABBVIE INC.
$1,871
Takeda Pharmaceuticals U.S.A., Inc.
$1,517
AbbVie Inc.
$871
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$860
Janssen Biotech, Inc.
$856
AbbVie, Inc.
$592
Daiichi Sankyo Inc.
$524
Intercept Pharmaceuticals, Inc.
$409
NuVasive, Inc.
$400
Gilead Sciences, Inc.
$377
Ethicon US, LLC
$351
BOSTON SCIENTIFIC CORPORATION
$291
PFIZER INC.
$266
PORTOLA PHARMACEUTICALS, INC.
$250
Ardelyx, Inc.
$246
Ipsen Biopharmaceuticals, Inc
$206
Boston Scientific Corporation
$192
AstraZeneca Pharmaceuticals LP
$191
QOL Medical, LLC
$151
INTERCEPT PHARMACEUTICALS, INC.
$144
E.R. Squibb & Sons, L.L.C.
$133
Ironwood Pharmaceuticals, Inc
$123
Merck Sharp & Dohme Corporation
$117
Janssen Pharmaceuticals, Inc
$101
Janssen Scientific Affairs, LLC
$101
UCB, Inc.
$99
Synergy Pharmaceuticals Inc
$99
Madrigal Pharmaceuticals
$89
Allergan Inc.
$74
Regeneron Healthcare Solutions, Inc.
$67
IRONWOOD PHARMACEUTICALS, INC
$66
Lilly USA, LLC
$64
Merck Sharp & Dohme LLC
$60
Intuitive Surgical, Inc.
$57
Celgene Corporation
$53
GENZYME CORPORATION
$46
RedHill Biopharma Inc.
$45
Shire North American Group Inc
$42
Nestle HealthCare Nutrition Inc.
$37
GlaxoSmithKline, LLC.
$35
Medtronic, Inc.
$34
Astellas Pharma US Inc
$30
Axonics, Inc.
$30
NESTLE HEALTHCARE NUTRITION INC.
$27
Mallinckrodt Hospital Products Inc.
$25
SERVIER PHARMACEUTICALS LLC
$25
Alnylam Pharmaceuticals Inc.
$23
Genentech USA, Inc.
$23
Alcresta Therapeutics, Inc.
$20
Seagen Inc.
$20
Pharmacosmos Therapeutics Inc.
$19
Acacia Pharma Inc
$16
Amgen Inc.
$15
TESARO, Inc.
$14
Organon LLC
$13
EISAI INC.
$12
Taiho Oncology, Inc.
$12
Teva Pharmaceuticals USA, Inc.
$11
Endogastric Solutions, Inc
$8
Top 3 companies account for 87.8% of total payments
Associated products mentioned in payments ›
AGILE · AGILE ESOPHAGEAL · ALIF · ANDEXXA · AVSOLA · Aemcolo · Amitiza · Axonics r-SNM System · BENDEKA · BYFAVO · Bylvay · CALQUENCE · CLENPIQ · CREON · Cimzia · Creon · DARZALEX · DIFICID · DUPIXENT · Da Vinci Surgical System · Dexilant · ENTYVIO · EOHILIA · EPIC BILIARY · ESOPHYX · EXALT · Entyvio · Epclusa · FASLODEX · GATTEX · GAUCHER-DISEASE · GI GENIUS · GIVLAARI · HABIB ENDOHPB · HUMIRA · Humira · IBSRELA · IMFINZI · INFLECTRA · INJECTAFER · INTERSTIM · IQIRVO · LINX Reflux Management System · LINZESS · Lenvima · Linzess · Lonsurf · Lunsumio · MAVYRET · MONOFERRIC · MOTEGRITY · MOVANTIK · MOVIPREP · Mavyret · Motegrity · NINLARO · OCALIVA · OMVOH · OPDIVO · PADCEV · PLENVU · REBYOTA · RELIZORB · REMICADE · RENFLEXIS · RESMETIROM · RINVOQ · Radial Jaw 4 · SHINGRIX · SIMPONI ARIA · SKYRIZI · SOMATULINE DEPOT · SPYGLASS · STELARA · SUCRAID · Sucraid · TAGRISSO · TERLIVAZ · TREMFYA · TRINTELLIX · Talicia · Tibsovo · Trulance · VELSIPITY · VIBERZI · VOQUEZNA · VOWST · Vanflyta · Venclexta · XALKORI · XARELTO · XELJANZ · XIFAXAN · XTANDI · ZEJULA · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in gastroenterology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for gastroenterology in TX.
Equivalent to $7,169 per 100 Medicare services performed
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Miller is a clinical cardiology specialist, with above-average Medicare volume (top 13% in TX), with speaking/promotional industry engagement in the top 3% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Miller experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Miller performed 269 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Miller receive payments from pharmaceutical companies?
Yes. Dr. Miller received a total of $101,946 from 62 companies across 727 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Miller's costs compare to other gastroenterologists in Temple?
Dr. Miller's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Miller) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Temple
Browse gastroenterologists in Temple ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in TX
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in TX
Which TX gastroenterologists receive the most from drug and device companies.
By company
Ferring Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Ferring Pharmaceuticals Inc.
By company
Phathom Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Phathom Pharmaceuticals, Inc.
By company
AIMMUNE THERAPEUTICS, INC. Payments to Doctors
See all physicians who received payments from AIMMUNE THERAPEUTICS, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology